MBX Biosciences, Inc. Common Stock
MBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | – | – | – |
| R&D Expenses | $57 | $29 | $21 |
| G&A Expenses | $11 | $7 | $4 |
| SG&A Expenses | $11 | $7 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $68 | $35 | $25 |
| Operating Income | -$68 | -$35 | -$25 |
| % Margin | – | – | – |
| Other Income/Exp. Net | $6 | $3 | -$1 |
| Pre-Tax Income | -$62 | -$33 | -$26 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$62 | -$33 | -$26 |
| % Margin | – | – | – |
| EPS | -1.85 | -1.02 | -0.82 |
| % Growth | -81.4% | -24.4% | – |
| EPS Diluted | -1.85 | -1.02 | -0.82 |
| Weighted Avg Shares Out | 33 | 32 | 32 |
| Weighted Avg Shares Out Dil | 33 | 32 | 32 |
| Supplemental Information | – | – | – |
| Interest Income | $6 | $3 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | -$68 | -$35 | -$26 |
| % Margin | – | – | – |